Assessment of relationship between galectin-3 and ambulatory ECG-based microvolt T-wave alternans in sustained systolic-diastolic hypertension patients
Authors:
- Ozgur AkgulOAOzgur Akgul
- Mehmet ErturkMEMehmet Erturk
- Ismail BolatIBIsmail Bolat
- Omer TasbulakOTOmer Tasbulak
- Vesile OrnekVOVesile Ornek
- Mehmet GulMGMehmet Gul
- Sinem O. OzyilmazSOSinem O. Ozyilmaz
- Hayriye A. YildirimHYHayriye A. Yildirim
- Uğur KokturkUKUğur Kokturk
- Emre YilmazEYEmre Yilmaz
- Ali K. KalkanAKAli K. Kalkan
- 1 October 2016
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 21 (5) , 265-270
Abstract
Galectin-3 is a marker associated with myocardial fibrosis and left ventricular myocardial index (LVMI). Myocardial fibrosis and LVMI have been reported in many studies to be associated with microvolt T-wave alternans (MTWA) positivity. In this study, galectin-3 levels of normotensive individuals and sustained systolic-diastolic hypertensive patients were compared and the association between galectin-3 levels and ambulatory ECG-based MTWA was investigated. A total of 184 individuals were included in the study, among whom, 43 were normotensive and 141 had sustained systolic-diastolic hypertension without cardiovascular or chronic renal failure. Galectin-3, MTWA, and LVMI were evaluated in all participants. Galectin-3 levels of hypertensive and normotensive participants were compared. The association between galectin-3, MTWA, LVMI, and estimated glomerular filtration rate (eGFR) was investigated in hypertensive patients. LVMI and galectin-3 levels were higher among hypertensive patients compared with normotensives (94.9±26.8 vs. 76.4±22.9 g/m, 7.325±2.123 vs. 5.233±1.506 ng/ml; P<0.001, P<0.001). Correlation analysis carried out among the hypertensive patients showed that the galectin-3 level was correlated positively to LVMI, age, and MTWA positivity (r=0.396, P<0.001; r=0.358, P<0.001; r=0.361, P<0.001, respectively), whereas it was correlated negatively to eGFR and male sex (r=-0.364, P<0.001; r=-0.280, P=0.001, respectively). Multiple logistic regression analysis indicated that LVMI and galectin-3 showed an independent association with MTWA positivity in hypertensive patients (P=0.003 and 0.005, respectively). Increased galectin-3 levels are associated with ambulatory ECG-based MTWA positivity, decreased eGFR, and increased LVMI in hypertensive patients. This association may be used for risk classification in this patient group.Keywords
This publication has 34 references indexed in Scilit:
- Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and SurvivalThe American Journal of Cardiology, 2011
- Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosisAmerican Journal of Physiology-Renal Physiology, 2011
- Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fractionAnnals of Medicine, 2010
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF studyClinical Research in Cardiology, 2010
- Assessment of Sympathetic Cardiovascular Drive in Human HypertensionHypertension, 2009
- N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectinAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Validation of the TONOPORT V ambulatory blood pressure monitor according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring Devices in AdultsBlood Pressure Monitoring, 2003
- Coronary angioplasty in cardiac transplant recipientsEuropean Heart Journal, 1993
- Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy.Heart, 1992
- Pathophysiologic significance of “stress” or relative polycythemia in essential hypertensionThe American Journal of Cardiology, 1976